GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
9/30/2018
9/30/2017
9/30/2016
Total Revenue
392,718
311,332
12,737
11,036
13,440
Cost of Revenue
32,837
27,199
5,986
4,744
3,543
Gross Profit
359,881
284,133
6,751
6,292
9,898
Operating Expense
434,162
402,558
295,554
204,874
156,039
Operating Income
-74,281
-118,425
-288,803
-198,581
-146,142
Net Non Operating Interest Income Expense
6,540
7,377
2,396
1,167
341.3859
Other Income Expense
102,939
101,845
-4,963
-6,759
33,518
Pretax Income
35,198
-9,203
-291,370
-204,173
-112,282
Tax Provision
2,118
-184
3,797
-27,754
-29,337
Net Income Common Stockholders
33,080
-9,019
-295,167
-176,419
-82,945
Diluted NI Available to Com Stockholders
33,080
-9,019
-295,167
-176,419
-82,945
Basic EPS
-
-
-0.0106
-0.007
-0.0037
Diluted EPS
-
-
-0.0106
-0.007
-0.0037
Basic Average Shares
-
-
27,828
25,286
22,573
Diluted Average Shares
-
-
27,828
25,286
22,573
Total Operating Income as Reported
-74,281
-118,425
-288,803
-205,340
-112,849
Total Expenses
466,999
429,757
301,540
209,618
159,582
Net Income from Continuing & Discontinued Operation
33,080
-9,019
-295,167
-176,419
-82,945
Normalized Income
34,187
-6,792
-291,147
-170,579
-107,539
Interest Income
7,646
8,464
3,645
2,165
566.8048
Interest Expense
1,106
1,087
1,249
998.0575
225.4189
Net Interest Income
6,540
7,377
2,396
1,167
341.3859
EBIT
36,304
-8,116
-290,121
-203,175
-112,057
EBITDA
45,783
-
-
-
-
Reconciled Cost of Revenue
32,837
27,199
5,986
4,744
3,543
Reconciled Depreciation
9,479
9,240
9,290
7,396
4,778
Net Income from Continuing Operation Net Minority Interest
33,080
-9,019
-295,167
-176,419
-82,945
Total Unusual Items Excluding Goodwill
-1,178
-2,272
-4,963
-6,759
33,293
Total Unusual Items
-1,178
-2,272
-4,963
-6,759
33,293
Normalized EBITDA
46,961
3,396
-275,868
-189,020
-140,571
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-70.8848
-45.44
-942.97
-918.7304
8,699